In mice, antagonism of Cxcr1 and Cxcr2 reduces pulmonary fibrosis, acting on endothelial cells, neutrophils, and fibroblasts, and mediating neutrophilic lung inflammation, angiogenesis, and fibrogenesis [245,246,302]. The gene discussed is CXCR2; the disease is pulmonary fibrosis.